Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer purchased ~$465K of EFX shares in the open market | OQRO

Home
Insider trades
Equifax
Officer purchased ~$465K of EFX shares in the open market

Insider trades

Insider trade

Officer purchased ~$465K of EFX shares in the open market

Traded Feb 18, 2026 · Filed Feb 19, 2026

EquifaxEFX

~$465K
Reported value · 2,400 sh @ $193.72: 11K
Holds after · shares reported: −26.0%
stock since the trade · S&P 500 +12.9%, $192.59 → $142.60 on Oct 5

Why it stands out

Equifax's Chief Product Officer paid $465K out of pocket for Equifax shares. The Equifax shares held grew by 29%.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 18, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 19, 2026

Officer$100K–$500KHoldings +29%

Context

Classification

open market purchase

Code P — open-market or private purchase

Absolute commitment

~$464,928

Shares × reported transaction price

Size band

$100K–$500K

Ownership change

+29.2%

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Purchase shares ÷ estimated pre-transaction holdings, from the filing

Rarity

Not enough history to judge

Confirmed open-market purchases by the same insider in the available history

Cluster activity

No other insider purchases within 30 days

Distinct insiders at the same issuer with confirmed open-market purchases

Size vs officer pay

This purchase equals about 7.4% of the average reported total pay of the company's named executive officers other than the CEO, fiscal 2025 ($6.32M)

An average across the officers named in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-03-27. This person may not be one of them, so it is not their own pay. A size comparison, not a judgement

Timing vs results

14 days after results of Feb 4, 2026, 62 days before results of Apr 21, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $192.59 on Feb 18, 2026, 10% above its 52-week low and 31% below its high, after a 13% drop over the previous 30 trading days

52-week range $175.05 (Feb 3, 2026) to $280.54 (May 19, 2025), 17% of the way up, from 251 adjusted closes. 30 trading days earlier: $220.79 on Jan 5, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+5.8%	−0.5%	+6.3%
30 days	−9.0%	−4.9%	−4.1%
90 days	−17.4%	+7.7%	−25.1%
180 days	−2.7%	+11.6%	−14.3%

Past results only. Not a forecast.

Source receipt

Record ID: 0001225208-26-002168
Filed / recorded: Feb 19, 2026, 9:22 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: EQUIFAX INC
Issuer CIK: 33185
Ticker: EFX
Reporting person: Cecilia Mao
Relationship: Officer
Officer title: EVP, Chief Product Officer
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Feb 18, 2026
Transaction code: P
Shares / units: 2,400
Price per share: $193.72
Acquired / disposed: Acquired (A)
Shares owned after: 10,623
Ownership form: Direct
Amendment: No

Footnotes from the filing

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/18/2025.
Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.